TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 4 | 0 | -4 | -9 | -31 | -51 | 32 | -11 |
S | %wins | 50 | 75 | 100 | 100 | 100 | 25 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/4/08 16:43 | 9/3/08 | AVII | Avi Biopharma Inc | OR | Health | Drug | Pharmaceutical Preparations | Kole Ryszard | OR | O | SVP | S | -43 | 1.12 | 0 | -38 | -2 | 1,841 | D | -72 | -57 | -14 | -15 | -7 | -4 | -2 | -3 | -2 | -2 | -10 | -50 | -49 | 53 |
9/3/08 18:49 | 9/2/08 | AVII | Avi Biopharma Inc | OR | Health | Drug | Pharmaceutical Preparations | Kole Ryszard | OR | O | SVP | S | -70 | 1.13 | 0 | -62 | -3 | 1,880 | D | -73 | -57 | -16 | -19 | -9 | -7 | -4 | -2 | 2 | 1 | -4 | -45 | -49 | 83 |
6/5/08 20:36 | 6/3/08 | AVII | Avi Biopharma Inc | OR | Health | Drug | Pharmaceutical Preparations | Kole Ryszard | OR | O | SVP | S | -6 | 1.40 | 0 | -4 | 0 | 1,941 | D | -70 | -52 | -44 | 1 | -11 | -12 | -7 | -3 | 1 | -15 | -11 | -15 | -56 | 15 |
5/21/08 19:36 | 5/20/08 | AVII | Avi Biopharma Inc | OR | Health | Drug | Pharmaceutical Preparations | Kole Ryszard | OR | O | SVP | S | -23 | 1.56 | 0 | -15 | -1 | 1,946 | D | -66 | -47 | -39 | 8 | -11 | 3 | 0 | 1 | 0 | -1 | -12 | -14 | -48 | -24 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |